Abstract:The FAS receptor-ligand system is a key regulator of apoptotic cell death, and loss of FAS expression and gain of FAS ligand (FASL) expression play important roles in the development and progression of cancer. Single-nucleotide polymorphisms in the promoter region of the FAS (G or A at position -1377 [FAS -1377G/A] and A or G at position -670 [FAS -670A/G]) and FASL (T or C at position -844 [FASL -844T/C]) genes alter the transcriptional activity of these genes. We examined the association between these polymorphisms and risk of the development and metastasis of esophageal squamous-cell carcinoma.Genotypes of 588 case patients with esophageal squamous-cell carcinoma and 648 control subjects were determined by polymerase chain reaction-based restriction fragment length polymorphism. Associations with the risk of esophageal squamous-cell carcinoma were estimated by logistic regression. All statistical tests were two-sided.We observed a statistically significantly increased risk of esophageal squamous-cell carcinoma associated with the FAS -1377AA (odds ratio [OR] = 1.79, 95% confidence interval [CI] = 1.29 to 2.48; P<.001) or FAS -670GG (OR = 1.72, 95% CI = 1.26 to 2.34; P<.001) genotype, which are in strong linkage disequilibrium compared with the FAS -1377GA or GG or the FAS -670AG or AA genotype, respectively. An increased risk of esophageal squamous-cell carcinoma was also associated with the FASL -844CC genotype (OR = 2.06, 95% CI = 1.64 to 2.59; P<.001) compared with the FASL -844CT or TT genotype. Gene-gene interactions of FAS and FASL polymorphisms increased the risk of esophageal squamous-cell carcinoma in a multiplicative manner (OR for the presence of both FAS -1377AA and FASL -844CC genotypes = 4.55, 95% CI = 2.75 to 7.48; P =.001, test for homogeneity). Statistically significant interactions were found between these polymorphisms in FAS and FASL and tobacco smoking. None of the polymorphisms was associated with risk of differentiation or metastasis of esophageal squamous-cell carcinoma at diagnosis.Genetic polymorphisms in the death pathway genes FAS and FASL appear to be associated with an increased risk of developing esophageal squamous-cell carcinoma.

Prognostic Role of Apoptosis-Related Gene Fas-1377 And-670 Polymorphisms in Breast Cancer

The Diplotype Fas −1377A/−670G As a Genetic Marker to Predict a Lower Risk of Breast Cancer in Chinese Women

Association Of The Polymorphisms In The Fas/Fasl Promoter Regions With Cancer Susceptibility: A Systematic Review And Meta-Analysis Of 52 Studies

Association Of Fas-1377 G/A Polymorphism With Susceptibility To Cancer

[Association Between Fas/Fas L Genes Promoter Polymorphisms and Pathogenic Risk of Cervical Cancer].

Functional Polymorphisms in Fas and Fasl Contribute to Increased Apoptosis of Tumor Infiltration Lymphocytes and Risk of Breast Cancer

[Association of XPC gene polymorphisms with breast cancer risk].

[Genetic Polymorphisms of Apoptosis-Associated Genes FAS and FASL and Risk of Colorectal Cancer].

Functional Polymorphisms in Cell Death Pathway Genes FAS and FAS Ligand and Risk of Prostate Cancer in a Chinese Population.

Distinct Role of the Fas Rs1800682 and FasL Rs763110 Polymorphisms in Determining the Risk of Breast Cancer among Han Chinese Females.

Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.

Functional Polymorphisms in FAS/FASL System Increase the Risk of Neuroblastoma in Chinese Population

Functional Polymorphisms in Cell Death Pathway Genes FAS and FASL Contribute to Risk of Lung Cancer

Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis

Apoptotic Variants As Predictors Of Risk Of Oropharyngeal Cancer Recurrence After Definitive Radiotherapy

Polymorphisms of Death Pathway Genes FAS and FASL in Esophageal Squamous-Cell Carcinoma

Fasl-844c Polymorphism is Associated with Increased Activation-Induced T Cell Death and Risk of Cervical Cancer

Functional Variants in Cell Death Pathway Genes and Risk of Pancreatic Cancer.

RESPONSE: Re: Polymorphisms of Death Pathway Genes FAS and FASL in Esophageal Squamous-Cell Carcinoma

Implication of Polymorphisms in the Promoter Region of Apoptosis-Related Genes in Survival of Gastric Cancer Patients.

Genetic Polymorphisms of FAS and FASL (CD95/CD95L) Genes in Cervical Carcinogenesis: an Analysis of Haplotype and Gene–gene Interaction